Literature DB >> 33191405

Germline variants of DNA repair genes in early onset mantle cell lymphoma.

Xiaogan Wang1,2, Yuqin Song1, Wei Chen2,3, Ning Ding1, Weiping Liu1, Yan Xie1, Yinan Wang4, Jun Zhu5, Changqing Zeng6,7,8.   

Abstract

Although somatic mutations of DNA repair genes are frequent in mantle cell lymphoma (MCL), our understanding of their germline defects is limited. In a Chinese family with maternal Lynch syndrome and paternal B cell non-Hodgkin lymphoma, one sibling developed both Lynch syndrome and MCL. Lynch syndrome is caused by heterozygous mutations in mismatch repair (MMR) genes. To understand the genetic predispositions in the family, we performed exome sequencing and analyses of affected individuals and their tumor samples. A novel germline indel, MLH1 Gly101fsX1, was identified as the cause of Lynch syndrome, and unstable microsatellite loci and mutational signatures as evidence of defective MMR were revealed in the MCL sample. Furthermore, we included additional 15 MCL patients with early onset, and found by exome sequencing that 11 patients carried heterozygous germline variants of 20 DNA repair genes, including MSH2 in MMR. In the MCL with MSH2 Arg359fsX16, unstable microsatellite loci and defective MMR signatures were also found. In addition, five patients also had heterozygous germline variants of genes involved in B cell functions. Thus, our study found germline variants of genes in single-strand break repair, double-strand break repair, and Fanconi anemia pathway in early onset MCL; and for the first time we identified germline defects of MMR in two MCLs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33191405     DOI: 10.1038/s41388-020-01542-2

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.

Authors:  Patricia Pérez-Galán; Martin Dreyling; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

Review 2.  Mantle Cell Lymphoma.

Authors:  Chan Yoon Cheah; John F Seymour; Michael L Wang
Journal:  J Clin Oncol       Date:  2016-01-11       Impact factor: 44.544

Review 3.  The molecular pathogenesis of mantle cell lymphoma.

Authors:  Niklas Vogt; Beiying Dai; Tabea Erdmann; Wolfgang E Berdel; Georg Lenz
Journal:  Leuk Lymphoma       Date:  2016-11-28

4.  Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M Dreyling; E Campo; O Hermine; M Jerkeman; S Le Gouill; S Rule; O Shpilberg; J Walewski; M Ladetto
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

Review 5.  Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions.

Authors:  Xose S Puente; Pedro Jares; Elias Campo
Journal:  Blood       Date:  2018-04-17       Impact factor: 22.113

6.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

Review 7.  Milestones of Lynch syndrome: 1895-2015.

Authors:  Henry T Lynch; Carrie L Snyder; Trudy G Shaw; Christopher D Heinen; Megan P Hitchins
Journal:  Nat Rev Cancer       Date:  2015-02-12       Impact factor: 60.716

Review 8.  Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

Authors:  Pedro Jares; Dolors Colomer; Elias Campo
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

9.  Differential DNA mismatch repair underlies mutation rate variation across the human genome.

Authors:  Fran Supek; Ben Lehner
Journal:  Nature       Date:  2015-02-23       Impact factor: 49.962

10.  The repertoire of mutational signatures in human cancer.

Authors:  Ludmil B Alexandrov; Jaegil Kim; Gad Getz; Steven G Rozen; Michael R Stratton; Nicholas J Haradhvala; Mi Ni Huang; Alvin Wei Tian Ng; Yang Wu; Arnoud Boot; Kyle R Covington; Dmitry A Gordenin; Erik N Bergstrom; S M Ashiqul Islam; Nuria Lopez-Bigas; Leszek J Klimczak; John R McPherson; Sandro Morganella; Radhakrishnan Sabarinathan; David A Wheeler; Ville Mustonen
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

View more
  1 in total

Review 1.  Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.

Authors:  Ryan J Stubbins; Sophia Korotev; Lucy A Godley
Journal:  Curr Hematol Malig Rep       Date:  2022-06-08       Impact factor: 4.213

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.